Previous 10 | Next 10 |
IRVINE, Calif., March 07, 2023 (GLOBE NEWSWIRE) -- Biomerica, Inc. (NASDAQ: BMRA) (“Biomerica”), a global provider of advanced medical products, announced today the closing of its previously announced underwritten public offering of an aggregate of 3,333,333 shares of its common sto...
Biomerica ( NASDAQ: BMRA ) has priced its public offering of ~3.3M shares of common stock at $2.40 per share, for gross proceeds of ~$8M. Craig-Hallum Capital Group is acting as sole managing underwriter for the offering. Net proceeds will be used for general corporate purpose...
IRVINE, Calif., March 03, 2023 (GLOBE NEWSWIRE) -- Biomerica, Inc. (NASDAQ: BMRA) (“Biomerica”), a global provider of advanced medical products, announced today the pricing of its previously announced underwritten public offering. Biomerica is offering an aggregate of 3,333,333 shar...
Shares of Biomerica ( NASDAQ: BMRA ) on Thursday fell 18.4% to $2.26 in postmarket trading, after the company announced a proposed public stock offering. All shares of common stock in the proposed offering are being offered by BMRA. The company said it intends to use the p...
IRVINE, Calif., March 02, 2023 (GLOBE NEWSWIRE) -- Biomerica, Inc. (NASDAQ: BMRA) (“Biomerica”), a global provider of advanced medical products, announced today that it has commenced an underwritten public offering of its common stock. All shares of common stock in the proposed offe...
HONOLULU, Jan. 23, 2023 (GLOBE NEWSWIRE) -- Barnwell Industries, Inc. (NYSE-American: BRN) (“Barnwell” or the “Company”) announce today that it has entered into a cooperation and support agreement (the “Agreement”) with its two largest stockholders, Alexa...
Biomerica press release ( NASDAQ: BMRA ): FQ2 net loss was $1.6M for the three months ended November 30, 2022 compared to a net loss of $1.1M for the three months ended November 30, 2021. Gross margin during the quarter ended November 30, 2022 increased to 24% as compared to a gro...
InFoods® IBS Data Receives American College of Gastroenterology Presidential Award (ACG) Following Presentation at Annual Scientific Meeting Trial Data Shows InFoods® IBS Treatment Diet Significantly Improved Several IBS Symptoms Including Abdominal Pain Intensity (API): In So...
Dr. Lacy is the former co-Editor in Chief of the American Journal of Gastroenterology, the former Editor in Chief of Clinical and Translational Gastroenterology, and has served as the co-Chairman for the Rome IV Committee on Functional Bowel Disorders . Dr. Lacy has authored over 225 peer rev...
Summary BMRA continues to advance on its pipeline, building momentum around its IBS product and H.Pylori diagnostic test. Despite these tailwinds, the market's reaction has been muted to each, with the equilibrium in price action reached almost immediately. Investors are still posit...
News, Short Squeeze, Breakout and More Instantly...
inFoods ® IBS patients can now conveniently self-collect a blood sample using a simple finger-stick methodology in the privacy of their home inFoods ® IBS test is the first of its kind to identify specific foods that can trigger an Irritable Bowel Syndrome (I...
Biomerica (NASDAQ: BMRA) , a biomedical technology company that develops, patents, manufactures and markets advanced diagnostics and therapeutic products, has entered into an at-market issuance sales agreement with EF Hutton LLC and R.F. Lafferty & Co. Inc. According to the company, the agree...
With IBS affecting 10 to 15% of the global population, the associated $21 billion in direct medical costs and absenteeism underscores the urgent need of innovative solutions. Recognized as the 7th most common diagnosis by all physicians, IBS represents a significant healthcare burden. inF...